CI Investments Inc’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,000
Closed -$1.65M 1256
2022
Q1
$1.65M Sell
3,000
-1,000
-25% -$604K 0.01% 394
2021
Q4
$2.64M Hold
4,000
0.01% 371
2021
Q3
$3.36M Hold
4,000
0.01% 374
2021
Q2
$5.08M Buy
+4,000
New +$4.51M 0.02% 349

Other funds holding CDLX

CI Investments Inc's CDLX Position: Q2 2022 in Review

CI Investments Inc sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 3,000 shares — an estimated $1.65M sold.

CI Investments Inc first reported a position in CDLX in Q2 2021 and held it in 4 quarters. The position peaked at $5.08M in Q2 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • CI Investments Inc reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • CI Investments Inc sold 3,000 Cardlytics shares in Q2 2022, an estimated $1.65M.
  • CI Investments Inc first reported a position in Cardlytics in Q2 2021 and held it in 4 quarters.
  • CI Investments Inc's Cardlytics position peaked at $5.08M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.